65lab Launches In Partnership With Evotec Se

By Author: Orson Amiri
Total Articles: 417
Comment this article

Lightstone Ventures, ClavystBio, Leaps by Bayer, Polaris Partners, and the Polaris Innovation Fund, along with Evotec SE, have launched 65LAB in Singapore. This unique collaboration aims to advance drug discovery and create new therapeutics companies. 65LAB will leverage global capabilities, financing, and networks to accelerate the commercialization of research from top academic and R&D institutions in Singapore. It plans to invest up to US$1.5 million in each project over 18-24 months, providing access to expertise and resources to develop breakthrough therapies. The initiative fosters long-term partnerships, supporting Singapore's biotech ecosystem, and aims to benefit global health.

Read More - https://www.techdogs.com/tech-news/pr-newswire/65lab-launches-in-partnership-with-evotec-se-and-backed-by-leading-global-investors-to-advance-drug-discovery-and-new-company-creation-in-singapore